Nordea Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
|
|||||
|
2025
Q1 | $850K | Buy |
|
|||||
|
2024
Q4 | $1.04M | Hold |
|
|||||
|
2024
Q3 | $875K | Sell |
|
|||||
|
2024
Q2 | $3.84M | Buy |
|
|||||
|
2024
Q1 | $3.68M | Sell |
|
|||||
|
2023
Q4 | $3.54M | Sell |
|
|||||
|
2023
Q3 | $3.28M | Buy |
|
|||||
|
2023
Q2 | $890K | Sell |
|
|||||
|
2023
Q1 | $966K | Sell |
|
|||||
|
2022
Q4 | $1.54M | Sell |
|
|||||
|
2022
Q3 | $2.1M | Sell |
|
|||||
|
2022
Q2 | $36.5M | Sell |
|
|||||
|
2022
Q1 | $48.6M | Sell |
|
|||||
|
2021
Q4 | $47.6M | Buy |
|
|||||
|
2021
Q3 | $44.1M | Buy |
|
|||||
|
2021
Q2 | $37.2M | Buy |
|
|||||
|
2021
Q1 | $18.6M | Buy |
|
|||||
|
2020
Q4 | $15.2M | Buy |
|
|||||
|
2020
Q3 | $10.8M | Sell |
|
|||||
|
2020
Q2 | $24.6M | Buy |
|
|||||
|
2020
Q1 | $7.76M | Buy |
|
|||||
|
2019
Q4 | $8.16M | Sell |
|
|||||
|
2019
Q3 | $12.3M | Buy |
|
|||||
|
2019
Q2 | $4.54M | Buy |
|
|||||
|
2019
Q1 | $3.44M | Buy |
|
|||||
|
2018
Q4 | $2.75M | Hold |
|
|||||
|
2018
Q3 | $4.74M | Buy |
|
|||||
|
2018
Q2 | $3.2M | Sell |
|
|||||
|
2018
Q1 | $3.06M | Buy |
|
|||||
|
2017
Q4 | $2.6M | Sell |
|
|||||
|
2017
Q3 | $2.43M | Sell |
|
|||||
|
2017
Q2 | $1.9M | Buy |
|